Search results
Results from the WOW.Com Content Network
AbbVie has been a long-term dividend investor's dream come true since it split from Abbott Laboratories in 2013. ... but it actually offers a juicy 3.6% at recent prices. AbbVie stock has been ...
And since it split from Abbott in 2013, AbbVie has increased its dividend by 310%. The stock's forward yield is now around 3.8%, compared to the S&P 500's average of 1.3%. So despite its recent ...
At recent prices, AbbVie stock offers a 3.7% yield. The company has more than quadrupled its dividend payout since spinning off from Abbott Laboratories in 2013.
AbbVie Headquarters: Abbott Park, Illinois ... It split off its research-based pharmaceuticals business into ... Abbott's year-end 2021 stock price was $140.74. [81 ...
Here's why they picked AbbVie (NYSE: ABBV), Amgen (NASDAQ: ... And since it split from Abbott in 2013, it has increased its payouts by 287.5%. ... At a forward price-to-earnings multiple of 16, it ...
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.It is ranked sixth on the list of largest biomedical companies by revenue.In 2023, the company's seat in Forbes Global 2000 was 74, [2] and rank 89 on the 2024 list. [3]
Today, AbbVie stock trades at a forward price-to-earnings (P/E) ratio under 15. That's a solid deal for a company with 8% expected growth and a dividend yielding 3.5% at its current share price.
And since it split from Abbott in 2013, AbbVie has raised its payout by 288%. The ability to maintain a solid dividend program for years is an incredibly attractive quality to long-term investors ...